Xcout IntelPhenomic AI competitors & alternatives
The 12 closest competitors and alternatives to Phenomic AI among biotechnology companies — ranked by similarity to what Phenomic AI actually does, not by market-cap band.
Subscribe to see Phenomic AI’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Phenomic AI
Phenomic AI Inc. is a biotechnology company developing novel antibody-based therapies directed against the tumor stroma to improve patient outcomes.
Phenomic AI at a glance
Phenomic AI is a biotechnology company headquartered in Canada. Its most recent funding round, Seed, raised $6M in October 2020. Xcout tracks 5 named people at Phenomic AI, including GIRISH AAKALU (CEO).
Phenomic AI leadership
- GIRISH AAKALUCEO
- Mike BriskinCSO, Chair SAB
- Sam CooperCTO
- Oren KrausCo-founder
- Chris HarveyVP of Research and Translational Development
Phenomic AI funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $6M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Phenomic AI competitors
Ranked by semantic similarity — how close each company is to Phenomic AI by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
9Bio Therapeutics is a biotechnology company that combines biology, structural engineering, and artificial intelligence to pioneer next-generation biologics for advanced cancers. The company is headquartered in Quebec, Canada.
Similar biotechnology company
Biolojic Design is an Israeli biotechnology company that uses computational modeling and artificial intelligence to design and engineer antibodies and other therapeutic proteins. It develops drug candidates and collaborates with pharmaceutical and biotechnology companies seeking novel biologic medicines.
Similar biotechnology company
Pharos iBio Co., Ltd. is a South Korean biotechnology company that uses artificial intelligence and big-data approaches for drug discovery and development. Its pipeline includes oncology candidates such as PHI-101, a FLT3 inhibitor being developed for acute myeloid leukemia and other cancers, serving patients with difficult-to-treat diseases and pharmaceutical development partners.
Similar biotechnology company
Prellis Biologics, Inc. is a privately held biotechnology company headquartered in Berkeley, California, within the San Francisco Bay Area. It develops human antibody therapeutics and focuses on antibody discovery leveraging AI and immune diversity.
Biotech
Lunai Bioworks Inc. (LNAI), formerly operating as Renovaro, is now dedicated to leveraging artificial intelligence for the creation of advanced medical treatments and the strengthening of biological defense systems. A significant project currently underway is the development of its specialized "Neurotoxicity Intelligence Technology."
Biotech
Atomic AI is a biotechnology research company specializing in RNA drug discovery utilizing atomic precision. Headquartered in San Francisco, California, the company combines machine learning and biology to develop advanced therapeutics.
Similar biotechnology company
immunitoAI is a TechBio research company founded in 2020 that develops AI-driven platforms to unlock the potential of antibody therapeutics. Headquartered in Bengaluru, Karnataka, India, the company employs a team of 11 to 50 professionals.
Similar biotechnology company
Monocacy Therapeutics Inc. develops artificial intelligence-guided, first-in-class immune medicines designed to restore optimal immune function and patient health. The company utilizes a full-stack, AI-powered immunology platform to discover and develop next-generation immunotherapies for patients.
Similar biotechnology company
Lantern Pharma Inc. is a clinical-stage biotechnology firm dedicated to revolutionizing drug development through the strategic application of artificial intelligence, machine learning, and comprehensive genomic data analysis. Their primary drug candidate, LP-100, is currently undergoing Phase II clinical trials, targeting metastatic, castration-resistant prostate cancer. The company is also advancing LP-300 as a potential combination therapy for non-small cell lung cancer adenocarcinoma, specifically in individuals who are non-smokers or have never smoked. Furthermore, their preclinical pipeline includes LP-184, an alkylating agent engineered to inflict DNA damage upon cancer cells that either overexpress specific biomarkers or exhibit mutations within their DNA repair pathways. Beyond these, Lantern Pharma maintains an antibody-drug conjugate (ADC) program for diverse cancer treatments. Central to their operations is the RADR artificial intelligence platform, which synergizes molecular data through advanced big data analytics and machine learning capabilities. Established in 2013, the company operates from its headquarters in Dallas, Texas.
Health Tech
Protai Bio is an Israeli biotechnology company leveraging artificial intelligence and proteomics to advance drug discovery pipelines.
Healthtech
GATC Health Corp. is a biotechnology company that uses artificial intelligence, genomics, and toxicology data to discover and develop therapeutics and predict drug safety. Its work is aimed at pharmaceutical and biotechnology partners as well as patients needing treatments for serious diseases.
Life Sciences
Northern Biologics is a biotechnology company developing antibody-based therapeutics, with a focus on treating cancer and targeting the tumor microenvironment. Its products are intended for oncology patients and clinical partners in the biopharmaceutical sector.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Phenomic AI and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Phenomic AIand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →